Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – Patients with bipolar disorder treated with more than one second-generation antipsychotic drug do not do any better than those treated with one drug,…
NEW YORK (Reuters Health) – Patients with overactive bladder (OAB) may do better with fesoterodine 8 mg/d than with tolterodine extended release 4mg/d, according to the results of…
NEW YORK (Reuters Health) – The high case mortality rate associated with H5N1 avian influenza in humans can be significantly reduced with oseltamivir therapy, even when started a…
NEW YORK (Reuters Health) – Rates of acute rejection of lung transplants are not improved when sirolimus is added to the immunosuppressive regimen instead of azathioprine, a multicenter…
NEW YORK (Reuters Health) – Results of a small study indicate that transdermal testosterone improves functional capacity and other parameters in elderly women with chronic heart failure. Writing…
NEW YORK (Reuters Health) – Children 1 to 3 years old with influenza benefit substantially from treatment with oseltamivir when it’s given within 24 hours of symptom onset,…
NEW YORK (Reuters Health) – Compared with unfractionated heparin, bivalirudin used for anticoagulation in unselected patients undergoing percutaneous coronary intervention is associated with less bleeding after 1 month…
NEW YORK (Reuters Health) – Patients with bronchiectasis not related to cystic fibrosis benefit significantly from regular twice-daily nebulized gentamicin therapy, a Scottish team reports in the American…
NEW YORK (Reuters Health) – The question of whether or not to add steroids to the treatment of pneumococcal meningitis seems to have been answered affirmatively by the…
NEW YORK (Reuters Health) – Atorvastatin plus vitamins C and E reduce the risk of developing hepatitic steatosis in patients with nonalcoholic fatty liver disease, or NAFLD, researchers…
